Elite Pharmaceuticals (ELTP) Common Equity (2011 - 2026)
Elite Pharmaceuticals' Common Equity came in at $104.83 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 119.8% from $47.68 million a year earlier and up 6.0% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Common Equity (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Common Equity was $98.88 million, up 84.8% from FY2025.
- Common Equity carries a five-year compound annual growth rate of 43.7% (FY2021 to FY2026).
- Going back by fiscal year, Common Equity was $53.52 million in FY2025 (-7.1%), $57.58 million in FY2024 (+98.8%), $28.96 million in FY2023 (+14.8%) and $25.22 million in FY2022 (+56.2%).
- The fiscal Q1 2027 figure represents the highest quarterly Common Equity in data going back to fiscal Q4 2011.
- Year-over-year, Common Equity has increased for four consecutive quarters, with growth averaging 39.2% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in fiscal Q3 2026 (growth of 120.4%), and the weakest in fiscal Q3 2025 (a decline of 21.5%).
- Business Quant data shows ELTP's Common Equity at $98.88 million (Q4 2026), $80.31 million (Q3 2026) and $61.58 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn | 104.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 104.83 Mn |
| Mar 31, 2026 | 98.88 Mn |
| Dec 31, 2025 | 80.31 Mn |
| Sep 30, 2025 | 61.58 Mn |
| Jun 30, 2025 | 47.68 Mn |
| Mar 31, 2025 | 53.52 Mn |
| Dec 31, 2024 | 36.45 Mn |
| Sep 30, 2024 | 47.27 Mn |
| Jun 30, 2024 | 58.25 Mn |
| Mar 31, 2024 | 57.58 Mn |
| Dec 31, 2023 | 46.41 Mn |
| Sep 30, 2023 | 45.09 Mn |
| Jun 30, 2023 | 30.12 Mn |
| Mar 31, 2023 | 28.96 Mn |
| Dec 31, 2022 | 30.17 Mn |
| Sep 30, 2022 | 27.19 Mn |
| Jun 30, 2022 | 25.53 Mn |
| Mar 31, 2022 | 25.22 Mn |
| Dec 31, 2021 | 22.79 Mn |
| Sep 30, 2021 | 20.50 Mn |
API Access
Elite Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();